New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 23, 2014
10:02 EDTASH, SQNM, RHP, REPYY, HSNI, FCN, EXPR, DAR, DISH, BURL, BBRY, BCRX, BCS, WHZOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Ashland (ASH) upgraded at KeyBanc... Barclays (BCS) upgraded at Canaccord... BioCryst (BCRX) upgraded to Outperform from Market Perform at Wells Fargo... BlackBerry (BBRY) upgraded at Evercore... Burlington Stores (BURL) upgraded to Buy from Neutral at Goldman... DISH (DISH) upgraded to Buy from Neutral at Citigroup... Darling (DAR) upgraded to Conviction Buy from Buy at Goldman... Express (EXPR) upgraded to Buy from Neutral at Janney Capital... FTI Consulting (FCN) upgraded to Outperform from Neutral at Macquarie... HSN, Inc. (HSNI) upgraded at Topeka... Nokia (NOK) upgraded to Market Perform from Underperform at Raymond James... Pearson (PSO) upgraded to Equal Weight from Underweight at Morgan Stanley... Repsol (REPYY) upgraded to Buy from Hold at Santander... Ryman Hospitality (RHP) upgraded to Buy from Hold at Deutsche Bank... Sequenom (SQNM) upgraded to Outperform from Market Perform at William Blair... Whiting USA Trust II (WHZ) upgraded to Outperform at Raymond James.
News For ASH;BCS;BCRX;BBRY;BURL;DISH;DAR;EXPR;FCN;HSNI;REPYY;RHP;SQNM;WHZ From The Last 14 Days
Check below for free stories on ASH;BCS;BCRX;BBRY;BURL;DISH;DAR;EXPR;FCN;HSNI;REPYY;RHP;SQNM;WHZ the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
September 22, 2014
13:39 EDTBCSFCA to fine Barclays GBP 38M over client assets, Sky News reports
Subscribe for More Information
07:05 EDTSQNMSequenom presents new data supporting accuracy of MaterniT21 test
Sequenom announced that its wholly owned subsidiary, Sequenom Laboratories, presented patient clinical data substantiating the performance of its MaterniT21 PLUS noninvasive prenatal test in the laboratory. An ad hoc analysis of 185,000 samples from patients at high-risk for fetal chromosome aneuploidy demonstrated stable positivity rates for trisomy 21, 18 and 13, which mirror the positivity rates found in large studies on high-risk populations utilizing invasive diagnostic procedures. Additionally, Sequenom Laboratories reported performance results from clinical testing with the MaterniT21 PLUS test with Enhanced Sequencing Series. In the ad hoc analysis based on voluntary outcomes provided by clinicians, the estimated sensitivity for trisomy 21, 18 and 13 were 99.3%, 98.3% and 97.4% respectively, and the estimated specificity was >99.9% for all three trisomies. These clinical laboratory performance data are equivalent to those published in the clinical validation studies of the MaterniT21 test. Based on these performance metrics, Sequenom Laboratories estimates that the MaterniT21 PLUS test positive predictive value for trisomy 21, 18 and 13 were 99.0%, 97.6% and 92.8% respectively, and the negative predictive value was >99.9% for all three trisomies.
06:30 EDTBBRYBlackBerry CEO's plan to abandon consumer market showing results, WSJ says
Subscribe for More Information
September 19, 2014
10:06 EDTEXPROn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:26 EDTBBRYBlackBerry global units stabilizing, says ITG Research
Subscribe for More Information
08:34 EDTBBRYBlackBerry volatility elevated into Q2 and outlook
Blackberry September weekly call option implied volatility is at 94, October weekly is at 75, October is at 59, November is at 52, December is at 54; compared to its 26-week average of 56 according to Track Data, suggesting large near term price movement into the expected release of Q2 results on September 26.
08:14 EDTEXPRExpress downgraded to Neutral from Buy at Goldman
Goldman downgraded Express to Neutral based on lackluster fundamentals as the pace of promotions in the quarter indicate a less robust margin recovery. The analyst believes shares reflect fundamentals and upside risk of a potential takeover. Price target lowered to $17 from $18.
September 18, 2014
12:08 EDTBCRXBioCryst receives additional NIAID funding for BCX4430
BioCryst announced that the National Institute of Allergy and Infectious Diseases exercised two additional options under its contract, which provides for GMP drug substance and drug product manufacture of BCX4430. Exercise of these options includes up to a $2M increase to the existing development contract. The contract modification and the two additional options exercised represent up to $4M to BioCryst in order to accelerate the development of BCX4430 as a treatment for hemorrhagic fever viruses, including Ebola virus and Marburg virus disease. NIAID, part of the National Institutes of Health, granted this five year term contract to BioCryst in September 2013. Approximately $19.9M of funding has been awarded to date under the contract. With this additional award, the BCX4430 development contract has been increased in value to $26.3M, if all options are exercised. This project is funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272201300017C.
07:52 EDTBCSUBS Chair says litigation bigger worry than stress test, Bloomberg reports
Subscribe for More Information
06:39 EDTBCSEuropean banks take out EUR83B of loans from central bank, NY Times says
European banks agreed to take out EUR83B in low interest loans from the European Central Bank, as part of a program in which all of the funds must be loaned to businesses or individuals, or repaid to the central bank within two years, according to The New York Times. Several analysts had said that they would be disappointed if banks took out less than EUR100B in loans, but a number of analysts said that a second round of the program, due to occur in December after stress tests have been completed, may be more popular, the newspaper stated. Publicly traded European banks include Banco Santander (SAN), Barclays (BCS), Credit Suisse (CS), Deutsche Bank (DB), HSBC (HSBC), ING Groep (ING), Lloyds Banking (LYG), Royal Bank of Scotland (RBS) and UBS (UBS). Reference Link
05:56 EDTBBRYStocks with implied volatility top IV index mean; AMD BBRY
Subscribe for More Information
September 17, 2014
15:50 EDTDISHDISH, DirecTV support committee passage of STAVRA legislation
DIRECTV (DTV) and DISH (DISH) issued the following statement regarding the passage of the Satellite Television Access and Viewer Rights Act, or STAVRA, out of the Senate Committee on Commerce, Science, & Transportation: "We thank Chairman Rockefeller, Ranking Member Thune and the rest of the Senate Commerce Committee for passing bipartisan legislation that makes important reforms to the outdated laws governing today’s video market, while ensuring continuity of service to more than 1.5M distant signal subscribers who would, otherwise, lose service at the end of this year. We look forward to working with Congressional leadership to see this reauthorization swiftly passed into law, and also look forward to continuing the important discussion regarding retransmission consent reform, and in particular protecting consumers from local channel blackouts.”
11:57 EDTSQNMSequenom management to meet with Maxim
Meetings to be held in New York on September 22 with a group luncheon also and in Boston on September 23 hosted by Maxim.
08:56 EDTDARDarling Valero and Valero's Diamond Green Diesel facility restarting production
Subscribe for More Information
07:43 EDTBCSBarclays, NY AG spar over fraud allegations, Reuters reports
Subscribe for More Information
September 16, 2014
14:44 EDTBCSVirginia AG files $1.15B lawsuit against banks that sold RMBS during crisis
Subscribe for More Information
11:05 EDTBBRYBlackBerry volatility elevated into Q2 and outlook
Subscribe for More Information
10:44 EDTSQNMSequenom lost Inter Partes Review to Ariosa, says Piper Jaffray
Subscribe for More Information
07:05 EDTDISHDISH, Scripps expand programming, digital rights in deal renewal
Subscribe for More Information
05:49 EDTBBRYStocks with implied volatility movement; YHOO BBRY
Stocks with implied volatility movement; Yahoo (YHOO) 61, BlackBerry (BBRY) 61 according to iVolatility.
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use